Covid-19: WHO expecting more info as it weighs approving India's Covaxin vaccine

accreditation
0:00
play article
Subscribers can listen to this article
A health worker draws a Covid-19 vaccine.
A health worker draws a Covid-19 vaccine.
Getty Images

The World Health Organisation said on Monday it expects Bharat Biotech to provide more information on its Covid-19 vaccine in a further setback to the Indian company's hopes of getting an emergency-use listing for the shot.

Without WHO's nod the two-dose Covaxin is unlikely to be accepted as a valid Covid-19 vaccine around the world. Bharat Biotech has been pursuing a WHO emergency-use listing for several months, having submitted data on a rolling basis since July.

"We are aware that many people are waiting for WHO's recommendation for (Bharat Biotech's) Covaxin to be included in the #COVID19 Emergency Use Listing, but we cannot cut corners," WHO said on Twitter.

READ | Don't use ivermectin to treat Covid-19 - Sahpra's stance aligns with US' FDA

Bharat Biotech did not immediately respond to a Reuters request for comment.

Covaxin is one of the three approved vaccines that have been used in India for the country's vaccination drive for adults. Around 30% of about 944 million eligible adults have been fully vaccinated so far, which includes the administration of more than 112 million doses of Covaxin.

"Bharat Biotech ... has been submitting data to WHO on a rolling basis and WHO experts have reviewed these data. WHO is expecting one additional piece of information from the company today," the global health agency said on Twitter.

WHO's chief scientist Soumya Swaminathan said on Sunday the agency's technical advisory group will meet on Oct. 26 to consider the listing for Covaxin.

We live in a world where facts and fiction get blurred
In times of uncertainty you need journalism you can trust. For only R75 per month, you have access to a world of in-depth analyses, investigative journalism, top opinions and a range of features. Journalism strengthens democracy. Invest in the future today.
Subscribe to News24
Lockdown For
DAYS
HRS
MINS
Voting Booth
President Ramaphosa has punted the idea of mandatory Covid-19 vaccinations for South Africans. This is:
Please select an option Oops! Something went wrong, please try again later.
Results
The right thing to do. We desperately need more South Africans vaccinated to prevent further mutations and restore normality in our lives.
72% - 8695 votes
A risky strategy. Compulsory vaccinations may have unintended consequences and damage our rollout campaign.
28% - 3420 votes
Vote
Rand - Dollar
15.83
+0.6%
Rand - Pound
21.01
+0.8%
Rand - Euro
17.92
+0.5%
Rand - Aus dollar
11.19
+0.9%
Rand - Yen
0.14
+0.6%
Gold
1,772.40
+0.3%
Silver
22.41
+0.1%
Palladium
1,850.00
+3.7%
Platinum
951.50
+1.2%
Brent Crude
69.67
+1.2%
Top 40
64,536
-0.0%
All Share
71,020
0.0%
Resource 10
67,074
-0.7%
Industrial 25
93,826
+0.2%
Financial 15
13,996
+0.8%
All JSE data delayed by at least 15 minutes Iress logo
Editorial feedback and complaints

Contact the public editor with feedback for our journalists, complaints, queries or suggestions about articles on News24.

LEARN MORE